Curis Reports Third Quarter 2012 Financial Results

[at noodls] – Conference Call Today at 9:00 am EST LEXINGTON, Mass., Nov. 6, 2012 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop next generation targeted small molecule … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard